Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H32N2O5 |
| Molecular Weight | 416.5106 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@H](C)C(=O)N2[C@@H]3CCC[C@@H]3C[C@@H]2C(O)=O
InChI
InChIKey=HDACQVRGBOVJII-YHUYVZNPSA-N
InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9805349
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9805349
Ramipril, (-)- is less active R-enantiomer than S-enantiomer. S-ramipril is angiotensin-converting enzyme (ACE) inhibitor, which is used for the treatment of hypertension.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5COV0OAU1T
Created by
admin on Mon Mar 31 22:06:50 GMT 2025 , Edited by admin on Mon Mar 31 22:06:50 GMT 2025
|
PRIMARY | |||
|
57183875
Created by
admin on Mon Mar 31 22:06:50 GMT 2025 , Edited by admin on Mon Mar 31 22:06:50 GMT 2025
|
PRIMARY | |||
|
1246253-05-3
Created by
admin on Mon Mar 31 22:06:50 GMT 2025 , Edited by admin on Mon Mar 31 22:06:50 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD